Home › Merck cancer drug is first approved under UK early access scheme
 

Keywords :   


Merck cancer drug is first approved under UK early access scheme

2015-03-11 18:18:18| Biotech - Topix.net

Merck & Co's cancer drug Keytruda, which works by boosting the immune system but has yet to be licensed in Europe, is the first medicine to be made available to patients in Britain under a new early access scheme. The Medicines and Healthcare Products Regulatory Agency said on Wednesday that the treatment had been cleared to treat adults and children from 12 years of age with advanced melanoma, the deadliest form of skin cancer, after other drugs had failed.

Tags: access early approved drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Leslie Graphics
06.10Hurricane Leslie Forecast Discussion Number 16
06.10Hurricane Leslie Wind Speed Probabilities Number 16
06.10Hurricane Leslie Forecast Advisory Number 16
06.10Hurricane Leslie Public Advisory Number 16
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Kirk Graphics
06.10Tropical Storm Milton Graphics
More »